Nikolai Petrovsky is a leading physician scientist in the area of vaccine development and artificial intelligence. He is Professor of Immunology and Infectious Disease at the Australian Respiratory and Sleep Medicine Institute in Adelaide and Research Director at Vaxine Pty Ltd, an Australian biotechnology company. He developed SpikoGen®/Covax-19, a protein-based COVID-19 vaccine licensed in the Middle East where 8 million doses were delivered, He is also the creator of Advax and CpG55.2, the latter being the first licensed human product created by artificial intelligence. He has authored over 300 peer-reviewed research papers, and his research has attracted over 50 million in funding from the US National Institutes of Health.